logo

For the Inventor, By the Inventor

Tsukuba, Japan

Kengo Sakaguchi

This inventor holds 16 USPTO granted patents and 3 EPO patents, primarily in Cancer Therapeutics. Top assignees: Toyo Suisan Kaisha, Ltd., Gunma University, M.t.3, Inc.. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kengo Sakaguchi. Retrieved from https://idiyas.com/inventor/kengo-sakaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16

% Patents Active = 43.8


Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 30(Granted Patents)


Company Filing History:

goldMedal12 out of 25 
 
Toyo Suisan Kaisha, Ltd.
 patents
silverMedal2 out of 115 
 
Gunma University
 patents
bronzeMedal2 out of 3 
 
M.t.3, Inc.
 patents
4. 1 out of 4 
 
Acteiive Corporation
 patents
5. 1 out of 8 
 
Kunimine Industries Co., Ltd.
 patents
6. 1 out of 141 
 
Tokyo University of Science Foundation
 patents
7. 1 out of 834,708 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Porphyrin Compound
Cancer Therapeutic Agent
Photosensitizer
Fluorescent Probe
Glucose Production
Protein Crystallization
Sulfonated Sugar Compounds
Immunosuppressive Agent
Sulfopyranosylacylglycerol
Medicament Derivatives
Tumor Treatment
Gastric Cancer
16 patents (USPTO):Explore Patents
1. 11643430 - Porphyrin compound or salt thereof, cancer therapeutic agent, photosensitizer, and fluorescent probe (2023-05-09),
2. 11267840 - Compound or salt thereof (2022-03-08),
3. 10316340 - Glucose production method and glucose produced by said method (2019-06-11),
4. 10175183 - Agent for searching for protein crystallization conditions and method of searching for protein crystallization conditions (2019-01-08),
5. 7973145 - Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same (2011-07-05),
6. 7378398 - Method for treating cancer (2008-05-27),
7. 7148200 - Method for treating cancer (2006-12-12),
8. 6919316 - Immunosuppressive agent (2005-07-19),
9. 6770629 - Administration of a sulfopyranosylacylglycerol to treat certain cancers (2004-08-03),
10. 6759522 - Sulforhamnosylacyglycerol derivatives and use thereof as medicaments (2004-07-06),
11. 6740640 - Sulfofucosylacylglycerol derivatives and administration thereof as medicaments (2004-05-25),
12. 6670361 - Method of treating cancer (2003-12-30),
13. 6518410 - Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments (2003-02-11),
14. 6518248 - Method of treating gastric or colon cancer by administration of a sulfoquinovosylacylglycerol ester (2003-02-11),
15. 6444795 - 1-0-(2-propenyl)-6-0-sulfonylpyranosides (2002-09-03),

Title: The Innovations of Kengo Sakaguchi

Introduction

Kengo Sakaguchi is an esteemed inventor based in Tsukuba, Japan. With a remarkable portfolio of 16 patents, he has been instrumental in advancing the field of chemical compounds and their applications in medicine.

Latest Patents

Among Kengo Sakaguchi's latest innovations is a porphyrin compound or a salt thereof, which serves as a cancer therapeutic agent and photosensitizer. His work includes the design and development of a fluorescent probe, expanding potential applications in various scientific fields. The porphyrin compound is represented by a specific formula and includes compounds that are composed of an aliphatic hydrocarbon group containing 10 to 26 carbon atoms.

Career Highlights

Kengo has made significant contributions to his field while working with prominent companies such as Toyo Suisan Kaisha, Ltd. and M.t.3, Inc. His extensive career is characterized by a focus on innovative chemical solutions aimed at improving health outcomes.

Collaborations

Throughout his professional journey, Kengo Sakaguchi has collaborated with notable individuals, including Fumio Sugawara and Takayuki Yamazaki. These collaborations have further enhanced the depth and impact of his innovations in various applications.

Conclusion

Kengo Sakaguchi stands out as a prominent figure in the realm of invention and innovation. His research and developments in porphyrin compounds and their applications in medical technology underscore his commitment to advancing scientific knowledge and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…